Daily non-political popular news in brief.
UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
05-17-2007 · EurekAlert!UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease's progression, symptoms and mortality.
Read more »
Keywords: southwestern, joins, national, clinical, trial, uncover, long-term, effects, west, nile, virus, join, long, term, effect, viru
« Previous | Next »
Similar news on "UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus":
- UT Southwestern joins national clinical trial that seeks to uncover long-term effects of West Nile virus
05-17-2007 · UT Southwestern Medical Center
UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease's progression, symptoms and mortality.
Similar news · Read more »
- NIAID DNA vaccine for H5N1 avian influenza enters human trial
01-03-2007 · EurekAlert!
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.
Similar news · Read more »
- Experimental MS drug shows promise, offers new window on disease
02-13-2008 · EurekAlert!
A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
Similar news · Read more »
- NIH report on intracranial stent points out need for upcoming large-scale clinical trial
02-13-2008 · EurekAlert!
A preliminary study funded by the National Institutes of Health found that a stent designed to open clogged arteries in the brain was successfully deployed in nearly all cases and significantly reduced arterial blockage in the short term. But data on the long-term benefit of the stent, compared to medical treatment alone, were inconclusive, prompting the upcoming launch of a large-scale randomized trial that is expected to provide definitive results.
Similar news · Read more »
- Humans MIFfed by West Nile Virus
10-01-2007 · EurekAlert!
Infection with West Nile Virus can cause lethal encephalitis and there are currently no vaccines or specific therapeutics for use in humans. However, a new study published in the Journal of Clinical Investigation has provided evidence that the proinflammatory soluble factor MIF might provide a target for developing therapeutics to treat WNV encephalitis.
Similar news · Read more »
- Researchers propose reason for severe side-effects of Northwick Park clinical trial
01-25-2007 · EurekAlert!
A possible reason why the Northwick Park clinical trial of the drug TGN1412 in the UK caused multiple organ failure in human volunteers is revealed in research presented today at a conference near Paris. The research shows that stimulating the molecule CD28 on cells that mediate the immune response, known as T cells, can have an adverse effect if these immune cells have been activated and altered by infection or illness in the past.
Similar news · Read more »
- Montana State University researchers investigate new suspect in West Nile deaths of pelicans
09-28-2007 · EurekAlert!
Stable flies are the latest suspect in the West Nile virus deaths of hundreds of pelican chicks at the Medicine Lake National Wildlife Refuge in northeast Montana.
Similar news · Read more »
- Silymarin does not affect virus activity or ALT levels in
02-01-2008 · EurekAlert!
In a survey of patients with chronic hepatitis C who participated in a National Institute of Diabetes and Digestive and Kidney Diseases-sponsored long-term treatment trial for patients who had failed to respond previously to antiviral therapy, approximately 40 percent acknowledged to interviewers at the time of enrollment that they were currently using or had in the recent past used herbal products for health purposes.
Similar news · Read more »
- Hepatitis C treatment reduces the virus but serious liver problems may progress
11-06-2007 · EurekAlert!
Patients with chronic hepatitis C and advanced liver disease who did not respond to previous standard therapy experienced significant decreases in their liver enzymes, viral levels, and liver inflammation following treatment with long-term pegylated interferon. However, the treatment did not slow or prevent the progression of serious liver disease. These findings come from the clinical trial, Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis, and were reported at the annual meeting of the American Association for the Study of Liver Disease
Similar news · Read more »
- Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
10-05-2006 · ScienceDaily
A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
Similar news · Read more »
